Armata Pharmaceuticals (ARMP) has provided an update.
Armata Pharmaceuticals, Inc. is set to present at the 2024 Military Health System Research Symposium with a poster that has been updated to reflect a completion projection increase from 75% to 80% for Q4 2024. They have also released a new corporate presentation on their website, replacing the previous one, and have stated that future updates may not always be announced with a formal report. The company emphasizes that these materials should be viewed alongside SEC filings and other public announcements and reserves the right to update information without obligation, except as legally required.
See more insights into ARMP stock on TipRanks’ Stock Analysis page.
